The Aβ (amyloid-β peptide) has long been associated with Alzheimer's disease, originally in the form of extracellular plaques. However, in the present paper we review the growing evidence for the role of soluble intracellular Aβ in the disease progression, with particular reference to Aβ found within the mitochondria. Once inside the cell, Aβ is able to interact with a number of targets, including the mitochondrial proteins ABAD (amyloid-binding alcohol dehydrogenase) and CypD (cyclophilin D), which is a component of the mitochondrial permeability transition pore. Interference with the normal functions of these proteins results in disruption of cell homoeostasis and ultimately cell death. The present review explores the possible mechanisms by which cell death occurs, considering the evidence presented on a molecular, cellular and in vivo level.
The consequences of mitochondrial amyloid β-peptide in Alzheimer's disease
- Views Icon Views
- Share Icon Share
- Cite Icon Cite
Kirsty E. A. Muirhead, Eva Borger, Laura Aitken, Stuart J. Conway, Frank J. Gunn-Moore; The consequences of mitochondrial amyloid β-peptide in Alzheimer's disease. Biochem J 15 March 2010; 426 (3): 255–270. doi: https://doi.org/10.1042/BJ20091941
Download citation file: